Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Suvmax in 18-Fluorodeoxyglucose PET/CT Potentially Predict the Estimation of a Positive Biopsy in Cases of Lymphoma

Pooja Chandra, Olufunke Akinbobuyi, Albert Liao, Jyoti Arora, MS, Zhengjia Chen, Mary J Lechowicz, MD, Amelia A. Langston, Jeanne Kowalsky, PhD, Jonathon B. Cohen, MD, Christopher R Flowers, Leon Bernal-Mizrachi, MD

Blood (2015) 126 (23): 5043.

https://doi.org/10.1182/blood.V126.23.5043.5043

Published: 2015

Journal Articles

Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R in MYC-Rearranged Aggressive B-Cell Lymphoma

Kieron Dunleavy, MD, Michelle Fanale, MD, Ann LaCasce, MD, Ariela Noy, Paolo Caimi, MD, Samir Parekh, MD, John W Hayslip, MD, Deepa Jagadeesh, MD MPH, Raymond S Lord, Mary J Lechowicz, MD, Rakesh Gaur, MD, Andrea Lucas, RN, Louis M Staudt, MD PhD, Seth M. Steinberg, PhD, Brad Kahl, MD, Jonathan W. Friedberg, MD, Richard F Little, MPH, MD, Nancy L Bartlett, MD, Wyndham H Wilson, MD PhD

Blood (2014) 124 (21): 395.

https://doi.org/10.1182/blood.V124.21.395.395

Published: 2014

Journal Articles

A Phase II Study Of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) As Front Line Therapy For Patients With Peripheral T-Cell Lymphoma (PTCL): Preliminary Results From The T- Cell Consortium Trial

Ranjana H. Advani, MD, Stephen M. Ansell, M.D., Ph.D., Mary J Lechowicz, MD, Anne W Beaven, MD, Fausto R. Loberiza, Jr., MD, MS, Kenneth R Carson, MD, Andrew M Evens, DO, MSc, Francine M. Foss, MD, Steven M. Horwitz, MD, Barbara Pro, MD, Lauren Pinter-Brown, MD, Sonali M. Smith, MD, Andrei R. Shustov, MD, Kerry J. Savage, MD, MSc, Julie M Vose, MD, MBA

Blood (2013) 122 (21): 3044.

https://doi.org/10.1182/blood.V122.21.3044.3044

Published: 2013

Journal Articles

Higher Numbers of Circulating Dendritic Cells and T-Cells Predict Response to Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease

Cynthia R. Giver, PhD, Mojtaba Akhtari, MD, Amelia A. Langston, MD, H. Jean Khoury, MD, Christopher R. Flowers, MD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, Mary J. Lechowicz, MD, Charise L. Gleason, NP, M. Louette Vaughn, RN, Edmund K. Waller, MD, PhD

Blood (2008) 112 (11): 1183.

https://doi.org/10.1182/blood.V112.11.1183.1183

Published: 2008

Journal Articles

Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study

Amelia A Langston, MD, Sujatha Murali, MD, Stephanie McMillan, RN, Leonard T. Heffner, MD, Sagar Lonial, MD, Edmund K. Waller, MD, PhD, Christopher R. Flowers, MD, Jonathan Kaufman, MD, Morgan L. McLemore, MD, Rajni Sinha, MD, Mary J Lechowicz, MD, H. Jean Khoury, MD, Elliott F. Winton, MD

Blood (2008) 112 (11): 3644.

https://doi.org/10.1182/blood.V112.11.3644.3644

Published: 2008

Journal Articles

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

Sagar Lonial, MD, Jonathan Kaufman, MD, Amelia A. Langston, MD, Leonard T. Heffner, MD, Claire Torre, Mary J. Lechowicz, MD, Christopher Flowers, MD, Stephanie McMillan, RN, Michael Arnold, Ned K. Waller, MD, PhD

Blood (2007) 110 (11): 949.

https://doi.org/10.1182/blood.V110.11.949.949

Published: 2007

Journal Articles

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

Sagar Lonial, MD, Claire Torre, Amelia A. Langston, MD, Stephanie McMillan, Ellie Hamilton, Christopher Flowers, MD, Mary J. Lechowicz, MD, Edmund K. Waller, MD, PhD

Blood (2005) 106 (11): 1960.

https://doi.org/10.1182/blood.V106.11.1960.1960

Published: 2005

Journal Articles

A Randomized Trial to Evaluate the Impact of Cytokines on Dendritic Cell, T-Cell and T-Cell Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant: An Interim Analysis.

Sagar Lonial, MD, Claire Torre, Michelle Hicks, Stephanie Mcmillan, Amelia A. Langston, MD, Christopher R. Flowers, MD, Mary J. Lechowicz, MD, Edmund K. Waller, MD, PhD

Blood (2004) 104 (11): 2854.

https://doi.org/10.1182/blood.V104.11.2854.2854

Published: 2004

Journal Articles

Predictors of More Rapid Lymphoid Reconstitution after Allogeneic Transplantation.

Martha L. Arellano, MD, Susan G. Moore, MD, MPH, Ragini Kudchadkar, MD, Christopher R. Flowers, MD, Amelia A. Langston, MD, Sagar Lonial, MD, Mary J. Lechowicz, MD, Edmund K. Waller, MD, PhD

Blood (2004) 104 (11): 3159.

https://doi.org/10.1182/blood.V104.11.3159.3159

Published: 2004

Journal Articles

A Phase I Trial of Ara-C, Topotecan, and Gemtuzumab Ozogamicin (Mylotarg®) for Advanced MDS and Secondary or Relapsed AML.

Amelia A. Langston, MD, Stephanie McMillan, RN, Sagar Lonial, MD, Kenneth Smith, MD, Edmund K. Waller, MD, PhD, Leonard T. Heffner, MD, Silvana Bucur, MD, Istvan Redei, MD, Christopher Flowers, MD, Mary J. Lechowicz, MD, Elliot Winton, MD

Blood (2004) 104 (11): 1814.

https://doi.org/10.1182/blood.V104.11.1814.1814

Published: 2004

NARROW

Suvmax in 18-Fluorodeoxyglucose PET/CT Potentially Predict the Estimation of a Positive Biopsy in Cases of Lymphoma

Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R in MYC-Rearranged Aggressive B-Cell Lymphoma

A Phase II Study Of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) As Front Line Therapy For Patients With Peripheral T-Cell Lymphoma (PTCL): Preliminary Results From The T- Cell Consortium Trial

Higher Numbers of Circulating Dendritic Cells and T-Cells Predict Response to Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease

Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

A Randomized Trial to Evaluate the Impact of Cytokines on Dendritic Cell, T-Cell and T-Cell Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant: An Interim Analysis.

Predictors of More Rapid Lymphoid Reconstitution after Allogeneic Transplantation.

A Phase I Trial of Ara-C, Topotecan, and Gemtuzumab Ozogamicin (Mylotarg®) for Advanced MDS and Secondary or Relapsed AML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only